1. Terry M. Fallout continues as third FDA panel member resigns over Aduhelm approval. Available at:https://www.biospace.com/article/3rd-fda-alzheimer-s-advisory-panel-member-resigns-over-biogen-approval/. Accessed June 17, 2021.
2. Lin GA, Whittington MD, Synnott PG, et al. Aducanumab for Alzheimer's disease: effectiveness and value; Draft Evidence Report. Institute for Clinical and Economic Review. Available at:https://icer.org/assessment/alzheimersdisease-2021/. Accessed June 17, 2021.
3. Extra-cranial factors in the development of Alzheimer's disease;Eiser;Brain Res,2020
4. The role of microbial infection in the pathogenesis of Alzheimer's disease and the opportunity for protection by anti-microbial peptides;Li;Crit Rev Microbiol,2021
5. Mechanisms of NLRP3 priming in inflammaging and age-related diseases;Gritsenko;Cytokine Growth Factor Rev,2020